Natera Inc
(NAS:NTRA)
$
124.39
0.95 (0.77%)
Market Cap: 15.38 Bil
Enterprise Value: 14.82 Bil
PE Ratio: 0
PB Ratio: 18.35
GF Score: 72/100 
Natera Inc at Robert W Baird Global Healthcare Conference Transcript
Sep 12, 2023 / 08:20PM GMT
Release Date Price:
$54.57
(-0.04%)
Catherine Walden Ramsey Schulte
Robert W. Baird & Co. Incorporated, Research Division - Senior Research Analyst
All right. Great. We're going to go ahead and get started. I'm Catherine Schulte. I cover life sciences and diagnostics here at Baird. Very excited to have Natera here presenting today. From the company, we have the CEO, Steve Chapman; and the CFO, Mike Brophy. So we're going to dive right into Q&A. But if you have a question for the team, you can send it to [email protected], and I will pass the one. So Steve, Mike, thanks for joining us.
Steven Leonard Chapman
Natera, Inc. - CEO, President & Director
Thanks for having us.
Michael B. Brophy
Natera, Inc. - CFO
Thanks for having us.
Questions & Answers
Catherine Walden Ramsey Schulte
Robert W. Baird & Co. Incorporated, Research Division - Senior Research Analyst
Maybe starting off on the women's health business and NIPT. Maybe just give us a picture of where we are today in terms
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers